ERCC2, KDM6A, and TERT as Key Prognostic Factors in Bladder Cancer: Insights from the AACR Project GENIE DatabaseSeptember 8, 2025OncologyGenitourinary Cancer
Papillary Cystadenocarcinoma: NCDB Insights on Outcomes and Socioeconomic DisparitiesSeptember 5, 2025OncologyGenitourinary Cancer
Can a Polygenic Risk Score Turn the Tide on Prostate Cancer Screening?April 30, 2025Genitourinary CancerMixed Topics
Do Patients With Intermediate-Risk Cervical Cancer Need Adjuvant Chemotherapy?March 24, 2025Genitourinary Cancer
ASCO Updates Treatment Guidance for Newly Diagnosed, Advanced Ovarian CancerFebruary 25, 2025Genitourinary Cancer
Next-Gen Sequencing Tumor Testing Remains Low in Prostate and Urothelial Cancer CasesFebruary 21, 2025Genitourinary CancerOncology
Service Connection Expanded to Additional CancersJanuary 31, 2025Prostate CancerLeukemia, Myelodysplasia, TransplantationMultiple MyelomaGenitourinary Cancer
VA Study Asks: Has Active Surveillance Solved the Problem of Overtreatment? January 28, 2025Prostate CancerOncologyGenitourinary Cancer
Agent Orange and Uranium Exposures Associated With Bladder Cancer Risk in VeteransJanuary 16, 2025Genitourinary CancerOncology
How Are Patients Managing Intermediate-Risk Prostate Cancer?December 12, 2024Genitourinary CancerOncology
New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?December 12, 2024Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Mixed TopicsOncologyGenitourinary CancerMelanomaLymphoma & Plasma Cell DisordersLung Cancer
Inside the Patient-Oncologist Bond: Why It’s Often So StrongDecember 2, 2024Breast CancerMixed TopicsGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
